This secondary analysis of a randomized clinical trial investigates the relative effectiveness and safety of the sodium-glucose cotransporter-2 inhibitor dapagliflozin for Black vs White patients with chronic kidney disease (CKD) in North and South America.
Recent Posts
- Navigating Inequality: A Student-Led Critical Study of Black First-Generation Students’ Experiences in South Africa
- Intellectual Capital as a Driver of Financial Performance and Market Value: A Comparative Analysis of Indonesia and Malaysia’s Property and Real Estate Sector
- The Well-Being of College English Teachers in China From the Perspective of Complex Dynamic Systems
- Early Teacher Identity Development and Big Five Personality Traits: A Canonical Correlation Analysis
- Negotiating Education-to-Employment Transitions: Educational Stratification, Institutional Uncertainty, and Employability Among International Vocational Education Students in China